Samyang Corpotation

Samyang Corp. News

• 

  Samyang Group’s Yang Young and Sudang Foundations Deliver Scholarship Funds - Delivered a total of KRW 1 billion scholarship funds to 131 high school, college and graduate school students - Funds covering full tuition as well as living expenses for students to focus on their studies - Supported around 23,000 students and 800 professors with tuitions and research funds since 1939     ▲ On 18th, Samyang Group’s Yang Young Foundation and Sudang Foundation delivered a total of KRW 1 billion scholarship funds to 131 high school, college and graduate school students from around the country.     Yang Young Foundation and Sudang Foundation of Samyang Group announced that they delivered scholarship funds for 2022 to 131 high school, college and graduate school students amounting to approximately KRW 1 billion:   Yang Young Foundation to 56 college and graduate school students and Sudang Foundation to 15 college students and 60 high school students. The recipients included underprivileged yet exemplary students with exceptional grades who were recommended by their respective schools. Prior to the outbreak of COVID-19, the two foundations held scholarship delivery ceremony at Samyang Group HQ and personally handed out the scholarship funds and certificates, but such event has been omitted since the pandemic.   The scholarships from the two foundations give high school students KRW 1 million a year and college students up to four semesters of full tuitions as well as living expenses to allow them to focus on their studies.   Based on its corporate philosophy for social contribution — “Provide an opportunity to make dreams come true” — Samyang Group is providing scholarship programs and academics support programs in basic sciences and humanities. Thus far, the two foundations have supported over 23,000 students and 800 professors and research groups with tuitions and research funds.   Samyang Group’s Yang Young Foundation was the first ever private scholarship foundation in Korea. It was founded by late Chairman Kim Yeon-su (pen name: Sudang) in 1939. Sudang Foundation was set up by Chairman Kim and his children in 1968 as a part of expansion of their scholarship programs. Along with scholarship programs, Sudang Foundation also runs Sudang Awards where they choose two accomplished professors in the fields of fundamental sciences, applied sciences and humanities with plaques and KRW 200 million prize money.   Details

• 

  Samyang Biopharm USA Appoints Ryu Eun-ju as Its New President - Expertise in new global pharmaceutical businesses and global marketing, such as global clinical trial management, licensing and global marketing - Has key capabilities in establishing and commercializing global strategies for anticancer drugs and treatment for rare diseases - “Plan to lay foundation for the growth in the long run by securing new R&D pipelines and expanding business portfolios”   ▲Ryu Eun-ju, New President of Samyang Biopharm USA   Samyang Biopharm USA, a global biopharmaceutical corporation under Samyang Group, announced on February 10 that Ryu Eun-ju has been newly appointed as its President.   Ryu brings more than 30 years of expertise in establishing new pharmaceutical business and marketing strategies such as global clinical trial management and licensing for global pharmaceutical companies.   She graduated from the College of Pharmacy at Ewha Womans University and earned her master’s degree in Clinical Pharmacy at Sookmyung Women’s University and MBA degree at New York University in the U.S. Ryu was the head of the Oncology & Specialty Business Unit at Pfizer Pharmaceuticals Korea, and has worked at the headquarters in the U.S. since 2006, showing expertise in various positions, such as Marketing Director of Japan and Asia, Portfolio Acquisition Director and Global Marketing Director. She also led the development of global clinic trials and new businesses in Bayer Korea and other medical companies in the U.S. Ryu was awarded by the Minister of Health and Welfare for contributing to the cooperation and development of the U.S.-Korea pharmaceutical bio-industries.   Lee Young-Joon, head of the Biopharmaceuticals Division, said, “Ryu has key capabilities in establishing and commercializing global strategies for anticancer drugs and treatment for rare diseases. She will contribute to Samyang Biopharm USA taking the next big step forward with her capabilities and experiences.”   Ryu commented, “I am happy to be the new President of Samyang Biopharm USA, striving to contribute to improving the quality of patients’ lives by developing innovative anticancer drugs. I plan to lay the foundation for the growth of Samyang Biopharm USA in the long run by securing new R&D pipelines and expanding business portfolios.”   Samyang Biopharm USA is an overseas corporation of Samyang Holdings established in the center of the global bio industry at Kendall Square, Boston in August 2018 with the goal of developing innovative oncology drugs and rare disease treatments. Samyang Biopharm USA intends to increase the speed and success rate of biopharmaceutical development by conducting global clinical trials of new oncology drug candidates studied by the Samyang Holdings Biopharmaceuticals Division in Korea through the implementation of the open innovation strategy that aims to introduce and develop new biopharmaceutical technologies and materials at an early stage by making the most out of its position. Currently, the company continues to search for new drug candidates targeting immunotherapy and rare disease treatments.     Details

• About Samyang Corp.Samyang pursues the vision of producing ?쏧ngredients that Add Value to Life??and endeavors to create a new future and a new Samyang.
• Corporate Social Responsibility ActivitiesOver its long history, Samyang Group has conducted diverse corporate social responsibility activities such as helping our neighbors, protecting the environment, contributing to the development of communities...
• IR InformationThis is financial information on Samyang Corp.

chemical

• Engineering Plastics Engineering Plastics more Engineering plastics are used as sophisticated materials for automotive, electrical/electronic, and machine parts.
• Ion Exchange Resins Ion Exchange Resins Detail Samyang Corp. is the only domestic maker and seller of ion exchange resins.
• EMS EMS more EMS provides the sevrvice related to the development of materials for displays, semiconductors, and IT

foodstuff